1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PROTAGONIST THERAPEUTICS INC
Protagonist Therapeutics Inc XNAS: PTGX

Protagonist Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline p...

Read More
83.24 -1.61 (-1.90%)
149.89% Gain from 52W Low
708.6K
XNAS Volume

XNAS 13 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
29.8 / 100
Momentum Score
Technically Bullish
74.3 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
90
1Yr Price target upside is 8%
13 analysts

18

S

12

W

5

O

1

T

SWOT Analysis

Protagonist Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..